Global Glucose Sensors Market: Is Glucose Sensors Beneficial for the Diabetic Patients?

Glucose Sensors Market

Glucose sensor is part of the continuous glucose monitoring that have the ability to detect and measure the glucose levels.  These sensors are usually inserted in the skin and sends data to the smart device, so one can easily manage their blood sugars level. One can easily manage their glucose level throughout the day. Such sensors are critical to provide information on the concentration of glucose in the body for oral glucose lowering medication or insulin therapy. These sensors can measure the interstitial glucose level which is the glucose found in the fluid between the cells. They have an alarm system which notifies the user whenever their glucose level is too high or too low. It can also keep track of the meals, medication, and other physical activities.

Access Full Report at  https://www.databridgemarketresearch.com/reports/global-glucose-sensors-market

Some of the factors responsible for the growth of Glucose Sensors Market are:

  • Rising number of diabetes patients: Diabetes is a condition that increases the blood sugar level of the body. For diabetes, the body either doesn't produce enough insulin or the insulin it produces can't be used effectively. It is important to treat diabetes because it can damage kidney, eyes, nerves, and other organs in the body. Type 1 diabetes, Type 2 diabetes, prediabetes, and gestational diabetes are some of the common types of diabetes. The main factor due to which there is increase the number of diabetes patients is because of the changing lifestyle and rising consumption of unhealthy food. Rising obese population is also expected to enhance the market growth
  •  Accurate and precise data of the sensor: These glucose sensors are very beneficial as they have the ability to track the changes of the glucose level in the body. They are mainly used by diabetic patient so they can keep the record of their shifting blood glucose level throughout the day. These sensors are place with an adhesive tape. The CGM machine tracks glucose levels continuously around the clock automatically, showing data every few minutes on a monitor.

The global glucose sensors market is segmented on the basis of product as invasive glucose monitoring, non-invasive glucose monitoring , self-glucose monitoring ,& lab-based glucose monitoring; technology as photo acoustic spectroscopy, optical coherence tomography, polarimetry, fluorescence, MIR spectroscopy, NIR spectroscopy, impedance spectroscopy, skin suction blister technique, sonophoresis, & reverse iontophoresis; component as sensors, transmitters & receivers, & integrated insulin pumps; demographics as adult population (>14 years), & children population (≤14 years and end users as hospitals, private clinics, home care, ambulatory settings, Others

Some of the launches and acquisition in the Glucose Sensors Market are:

  • In September 2019, Medtronic announced the launch of their Envision Pro Continuous Glucose Monitoring (CGM) system. This new system is a fully disposable, and zero calibration professional CGM system. The new technology would allow healthcare professionals and their patients with type 1 and type 2 diabetes to see appropriate levels of glucose and patterns over time to develop more effective strategies for diabetes therapy. This will also help the patient to track their glucose level and know when their sugar is high or low

  • In July 2018, Abbott announced that they have received approval from the U.S. Food and Drug Administration for their FreeStyle Libre 14 day Flash Glucose Monitoring system. This new system will help the diabetes patient to wear sensor upto 14 days with high accuracy.

“According to Data Bridge Market Research, Global Glucose Sensors Market is set to witness a healthy CAGR of 19.4% in the forecast period of 2019- 2026”

Some of the major players operating in global glucose sensors market are AstraZeneca, BD, Eli Lilly and Company, Biocon, Sanofi, Smiths Group plc., Wockhardt Limited, Novo Nordisk A/S, Nipro, InjexUK, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Ypsomed, Mannkind Coroporation, Arkray, B. Braun Melsungen AG, Dexcom, Inc., Sannuo biosensor Ltd. and Bio-Rad Laboratories, Inc. among others.

Increasing cases of diabetes among population and rising demand for advanced continuous glucose monitoring system are the factors responsible for the growth of this market. Increasing popularity of home-based treatment and self-medication has also accelerated the popularity of glucose sensors. People are also using these sensors because they save time and provide accurate results to the patients. These are some of the factors which are expected to drive the market growth in the forecast period.

Browse in Healthcare Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/